Therapeutics News

DermTech, a commercial stage molecular dermatology company developing non-invasive genes expression tests for clinical diagnosis in skin cancer and inflammatory skin conditions, announced that it has added Matthew Posard to its board of directors.

Most surveyed dermatology patients preferred professional attire, including a white coat, for their dermatologists across treatment settings, according to study results recently published in JAMA Dermatology.

Pfizer announced in a press release its executive leadership team for the combined Pfizer and Allergan business following the close of the proposed merger of the companies.

Delivery of Dalvance in a single dose could result in safety and efficacy outcomes similar to those provided by the currently approved schedule, which breaks the antibiotic treatment into two separate infusions, according to new data published in Clinical Infectious Diseases.

Study results finding that patients with severe nail dystrophy related to alopecia universalis who were treated with Xeljanz experienced normal nail growth was the most read-article of the past week on Healio.com/Dermatology.

The American Skin Association announced that Robert Modlin, MD, has become co-chair of its medical advisory committee.

Healio.com will provide coverage of the American Society for Dermatologic Surgery Annual Meeting in Chicago beginning Thursday.

The rate of systemic comorbidities for patients with rosacea was associated with rosacea severity, according to recent study results.

Provectus Biopharmaceuticals announced financial results of its second quarter of 2015 and provided updates on the development of new therapies for dermatology and oncology.

VANCOUVER, British Columbia — Albinism, a genetic disorder in which people lack pigment and do not produce melanin, will be a focus of the World Congress of Dermatology.